Biliary atresia, a progressive sclerosis of the extrahepatic biliary tree that occurs only within the first 3 months of life, is one of the most common causes of neonatal cholestasis and accounts for ...
My baby was diagnosed with biliary atresia when he was 2 months old. While Google helped me identify his symptoms, it was a doctor who listened and diagnosed him. He had surgery to repair his bile ...
News-Medical.Net on MSN
New insights into long-term liver injury after Kasai portoenterostomy for biliary atresia
BA is characterized by early destruction of the bile ducts, leading to cholestasis, inflammation, and rapid fibrosis shortly ...
Biliary atresia (BA) is a life-threatening liver disease of infancy in which early surgery can restore bile flow but rarely ...
A nationwide consortium of researchers has identified the first genetic defect linked to biliary atresia, a mysterious liver disease that is the leading cause for liver transplantation in children.
This study found significant inter-hospital variability in the age at which Kasai portoenterostomy for biliary atresia is performed in tertiary children's hospitals in the United States. Improved ...
ATLANTA - They say becoming a mother is like watching your heartbeat outside your own body. But 6-year-old Julia Navarro and her mother, Analy, give that saying new meaning. Childbirth is already ...
A research team from China characterized the differentially expressed gene profiles in livers from biliary atresia (BA) patients. They found that RRAS gene and its related MAPK pathway are important ...
Please provide your email address to receive an email when new articles are posted on . A new ultrasound approach helped identify patients later diagnosed with biliary atresia. The method would ...
Healio spoke with Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, about a presentation at The Liver Meeting on how blocking nuclear factor kappa B could correct cellular ...
The Biliary Atresia market size is expected to grow steadily at a CAGR of 7.7% (2024–2034), driven by rising incidence, better diagnostics, and wider treatment adoption. In 2023, there were about 609 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results